0001628280-25-038378
SEC filingNotes reveal $224.5M in remaining performance obligations, $210M in convertible debt, and a $30M legal settlement funded by insurance.
As of June 30, 2025, Cerence held $73.7M in cash and cash equivalents and $5.5M in marketable securities, totaling $79.2M in liquid assets. Total debt stood at $210.0M principal ($198.8M carrying value), consisting of $122.5M in 1.50% Senior Convertible Notes due 2028 and $87.5M in 2025 Modified Notes (also due 2028). The company repaid the remaining $61.0M of the original 2025 Notes at maturity in Q3 FY2025, and repurchased $27.4M of those notes earlier in the fiscal year. Shareholders' equity was $155.7M, up from $141.1M at September 30, 2024, driven by stock-based compensation and common stock issuances. Inventory was $1.9M, primarily related to the Cerence Link product.
Remaining performance obligations (RPO) totaled $224.5M as of June 30, 2025, with $85.9M expected within one year, $82.9M in years two to five, and $55.8M beyond five years. Deferred revenue was $185.99M, up from $167.2M at September 30, 2024. The company had $0.7M in letters of credit for facility leases. A $30.0M legal settlement related to the Securities Action was fully paid by insurance proceeds in Q1 FY2025. The company is involved in a BIPA class action and a patent infringement counterclaim by Samsung, for which no loss estimate is currently possible.
No share buybacks or dividends were reported. Capital expenditures were $11.4M for the nine months ended June 30, 2025 (5.9% of revenue). Debt reduction was the primary capital allocation action: $87.5M in principal was repaid (including $61.0M at maturity and $27.4M in open-market repurchases), resulting in a net debt decrease of $87.5M. The company terminated its $50.0M revolving credit facility on December 31, 2024.
The company operates as a single reporting segment. Geographic revenue for the nine months ended June 30, 2025: United States $29.7M, Germany $60.6M, Japan $30.8M, Other Asia-Pacific $52.1M, Other Europe/Middle East/Africa $17.1M, Other Americas $0.9M. Korea contributed $26.2M and China $17.6M. One customer accounted for 12.5% of total revenue in the nine-month period.
Despite a net loss of $5.4 million, operating cash flow was strongly positive at $48.4 million, reflecting large non-cash adjustments: $20.0 million stock-based compensation, $8.5 million depreciation/amortization, and a $4.6 million non-cash interest expense. Additionally, working capital provided $28.7 million, notably from a $27.1 million decrease in prepaid expenses and a $17.1 million increase in deferred revenue, offset by a $17.1 million decrease in accrued expenses.
Capital expenditures of $11.4 million (23.5% of CFO) increased sharply from $3.6 million a year ago, signaling higher investment in fixed assets. Free cash flow (CFO - capex) would be $37.0 million, though not explicitly stated.
Financing cash flow was a large outflow of $87.4 million, dominated by $87.1 million in short-term debt principal payments. Share repurchases were limited to $2.2 million for tax withholdings on equity awards, with no dividends paid.
The large swing in deferred revenue (from -$70.6 million to +$17.1 million) and the prior year's $609 million goodwill impairment (non-cash) distort year-over-year comparisons. The company's cash position declined $47.8 million, ending at $73.7 million.